Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
751.00    12.50 (1.69%)
Bid:
748.00
Ask:
751.00
Spread: 3.00 (0.401%)
Market Cap: £855.69m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Pre-Close Trading Statement

22 Jan 2015 07:00

RNS Number : 8145C
Fevertree Drinks PLC
22 January 2015
Β 

22nd January 2015

Β 

Fevertree Drinks plc ("Fever-Tree")

Β 

Pre-Close Trading Statement

Β 

Fever-Tree, the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, today announces its pre-close trading update for the year ended 31 December 2014.

Β 

The Board is pleased to announce that Fever-Tree continued to perform strongly in the second half of 2014. It is anticipated that sales in the second half will be ahead of the prior year period by 43%, notwithstanding the strong comparatives in the second half of 2013. Full year revenue is expected to be circa Β£34.7 million, reflecting growth of 49% on 2013.

Β 

Sales in the UK continued to perform well in the second half of 2014 and, following a very strong Christmas period, full year revenue is expected to be circa 60% ahead of 2013. UK sales of our Indian tonic water were particularly robust as the trend for consumers seeking a premium quality gin and tonic experience continued.

Β 

In the USA, notable sales growth was achieved in the final quarter of the year as a result of strong trading during the Thanksgiving and Christmas periods and full year revenue is expected to be circa 59% ahead of 2013.

Β 

Sales in the Rest of Europe also performed well in the second half of 2014 and it is anticipated that full year revenue will be circa 35% ahead of 2013.

Β 

Rest of World sales growth in the second half of 2014 was slightly ahead of expectations and full year revenue is expected to be circa 58% ahead of 2013.

Β 

Over the period, Fever-Tree's free cash flow generation and balance sheet have remained strong, with the year-end net cash position anticipated to be in line with expectations.

Β 

FY14 expectations

Β 

Given the strong sales in the final two months of the year, the Board anticipates that the outcome for the full year will be comfortably ahead of its expectations.

Β 

Fever-Tree will announce its Preliminary Results on 23 March 2015.

Β 

Commenting on today's announcement, Tim Warrillow, CEO of Fever-Tree said:

Β 

"We are encouraged to report such a strong trading statement, our first as a public company. Fever-Tree continues to trade well, buoyed by a strong festive period and growth in all of our regions and we look to the future with confidence."

Β 

Β 

For further information:

Β 

Fevertree Drinks plc

c/o FTI +44 (0)20 3727 1000

Tim Warrillow, Co-founder and CEO

Β 

Charles Rolls, Co-founder and Executive Deputy Chairman

Β 

Andy Branchflower, Finance Director

Β 

Β 

Β 

FTI Consulting - Financial PR

+44 (0)20 3727 1000

Jonathon Brill

fever-tree@fticonsulting.com

George Hudson

Β 

Georgina Goodhew

Β 

Β 

Β 

Investec Bank plc - Nominated Adviser and Broker

+44 (0)20 7597 4000

Garry Levin

Β 

Duncan Williamson

Β 

Matt Lewis

Β 

David Anderson

Β 

Β 

Β 

Β 

Notes to Editors:

Β 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). Approximately 70 per cent of the Group's sales were derived from outside of the UK in financial year 2014, with key overseas markets in the US and Europe.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTFMGZMRMLGKZM
Date   Source Headline
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSCommencement of share buyback programme
10th Feb 20251:35 pmRNSHolding(s) in Company
7th Feb 20254:35 pmRNSHolding(s) in Company
7th Feb 20254:07 pmRNSHolding(s) in Company
7th Feb 20254:05 pmRNSHolding(s) in Company - correction
6th Feb 202511:39 amRNSHolding(s) in Company
5th Feb 20255:39 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSCompletion of Share Issuance to Molson Coors
3rd Feb 202512:20 pmRNSStandard form for notification of major holdings
30th Jan 20253:01 pmRNSDirector/PDMR Shareholding
30th Jan 20257:02 amRNSUS Strategic Partnership with Molson Coors
20th Jan 20257:00 amRNSAppointment Of Corporate Broker
6th Jan 20252:15 pmRNSStandard form for notification of major holdings
2nd Dec 202411:47 amRNSStandard form for notification of major holdings
2nd Dec 20247:00 amRNSBlock Listing Return
2nd Dec 20247:00 amRNSTotal Voting Rights
28th Nov 20245:12 pmRNSStandard form for notification of major holdings
18th Sep 20242:42 pmRNSStandard form for notification of major holdings
12th Sep 20247:00 amRNSFY24 Interim Results to 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
6th Jun 20241:29 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Trading Statement
3rd Jun 20247:00 amRNSBlock Listing Return
3rd Jun 20247:00 amRNSTotal Voting Rights
9th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSGrant of Options
1st May 20247:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSAdmission Application
18th Jan 20242:30 pmRNSBlock Admission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.